This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Gale Lee Hansen and Cancer-Treatment Innovation.
Introduction
Gale Lee Hansen is an inventor associated with Ridgefield, Connecticut, and Boehringer Ingelheim Pharmaceuticals, Inc. Her patent work includes an invention concerning binding molecules for cancer treatment.
Latest Patents
Hansen is listed as an inventor on 1 patent: “Binding Molecules for the Treatment of Cancer.” The invention focuses on binding molecules with potential applications in cancer treatment.
Career Highlights
Hansen’s patent record connects her work to pharmaceutical research and the development of cancer-treatment technologies at Boehringer Ingelheim Pharmaceuticals, Inc.
Collaborations
Her listed coworkers include Srinath Kasturirangan and Andreas Wernitznig, reflecting collaborative contributions to pharmaceutical innovation.
Conclusion
Gale Lee Hansen’s patent on binding molecules for cancer treatment represents her documented contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile